Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer Therapy
Clinical trial recommended to further test combination of carboplatin and PLD
November 10th, 2005
A clinical trial is recommended to further test combination of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies. "The results of a multicenter phase II study investigating carboplatin and pegylated liposomal doxorubicin (PLD) in patients with recurrent/metastatic uterine and cervical malignancies (UCM) are presented" in the a recent report in the International Journal of Gynecological Cancer. "Fifty-three subjects with measurable, untreated, advanced UCM were enrolled" in the study," wrote H. Le and colleagues. "Fifty-one were evaluable for response. Prior combined-modality treatment was permitted if a...
Source: Women's Health Weekly (2005-11-10)
|
